Nucleic acid encoding α chain of human IL-11 receptor
AssigneeAmrad Operations Pty. Ltd.
InventorDouglas James Hilton
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range of agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.
Claims3
An isolated nucleic acid molecule wherein the nucleic acid molecule encodes an α chain of human Interleukin (IL)-11 receptor wherein said IL-11 receptor comprises the amino acid sequence set forth in SEQ ID NO:5.
Dependencies are inferred from the claim text.